Stock Report

All about this stock under one free report Last Updated: 13-Nov-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Nephrocare Health Services Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: NEPHROPLUS | BSE: 544647

₹651.05

up-down-arrow ₹28.40 (4.56%)

As on 13-Nov-2026IST

Market cap

info icon

₹6,302 Cr

Revenue (TTM)

info icon

₹1,111 Cr

P/E Ratio

info icon

49.2

P/B Ratio

info icon

5.3

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 7.68 23.47 24.78 31.70 --
EBIT 0.24 -2.59 15.29 329.85 --
Net Profit 4.87 453.93 116.38 104.23 --
EPS 4.64 163.67 -64.85 36.89 --
Book Value -- -- -82.99 -36.79 --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info 11.34--13.1213.6512.46
Net Margin info 7.45--12.167.518.71
Return on equity info 10.68--11.119.2213.81
Return on Capital info 13.18----16.1814.76
Return on Assets info 6.30--16.986.377.63
Debt to Equity (x) info ----0.000.020.40

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
--
16.18
14.76
8.59
1.31
Peer Median
--
19.91
20.26
19.83
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

11.11

Lower than Peers by 3.96

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
11.11
9.22
13.81
9.00
-3.13
Peer Median
15.08
14.46
13.93
15.80
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

16.98

Higher than Peers by 6.64

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
16.98
6.37
7.63
4.91
-1.81
Peer Median
10.34
8.69
10.00
8.30
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

13.12

Lower than Peers by 5.62

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
13.12
13.65
12.46
7.91
0.39
Peer Median
18.74
18.48
19.66
18.70
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

12.16

Lower than Peers by 1.50

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
12.16
7.51
8.71
6.11
-2.66
Peer Median
13.65
11.85
11.96
12.26
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
--
16.77
18.47
16.12
8.02
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

24.78

Higher than Peers by 9.00

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
24.78
32.16
33.50
29.47
--
Peer Median
15.78
24.63
15.74
13.67
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

15.29

Lower than Peers by 1.92

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
15.29
44.74
110.32
2,509.15
--
Peer Median
17.21
28.44
22.60
11.16
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

116.38

Higher than Peers by 96.39

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
116.38
14.52
90.98
398.02
--
Peer Median
19.99
24.17
23.29
9.39
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-64.85

Lower than Peers by 77.01

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
-64.85
-89.93
89.25
396.48
--
Peer Median
12.16
-11.91
29.43
-7.32
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
--
93.44
40.59
7.11
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
--
0.02
0.40
0.60
0.52
Peer Median
--
0.02
0.05
0.08
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
--
0.01
0.17
0.22
0.24
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

2.42

Higher than Peers by 0.26

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
2.42
2.80
1.92
1.61
1.86
Peer Median
2.16
2.63
2.42
2.28
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

2.30

Higher than Peers by 0.27

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
2.30
2.69
1.83
1.50
1.71
Peer Median
2.02
2.45
2.37
2.33
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

12.18

Higher than Peers by 2.02

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
12.18
2.62
5.20
2.64
0.47
Peer Median
10.16
7.95
7.61
10.16
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

29.50

Higher than Peers by 20.01

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
29.50
31.73
35.25
35.80
36.25
Peer Median
9.49
10.35
10.62
7.60
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

1.36

Higher than Peers by 0.59

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
1.36
0.83
0.86
0.79
0.67
Peer Median
0.77
0.83
0.81
0.77
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
--
106.58
113.27
116.42
132.30
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
--
10.90
12.69
16.82
21.93
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
--
205.92
172.42
123.18
110.84
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
--
-88.44
-46.47
10.06
43.39
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

49.19

Lower than Peers by 8.60

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
49.19
66.02
--
--
--
Peer Median
57.79
55.85
59.48
60.28
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

5.30

Lower than Peers by 3.65

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
5.30
4.62
--
--
--
Peer Median
8.95
8.36
9.63
8.84
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
--
--
--
--
--
Peer Median
0.39
0.14
0.04
0.42
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

22.24

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
22.24
19.25
0.42
1.71
3.43
Peer Median
--
47.57
48.17
47.88
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

6,302

Lower than Peers by 8,265

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Nephrocare Health Services
6,302
5,073
--
--
--
Peer Median
14,567
13,148
8,622
9,694
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month